Weekend reads: A bizarre turn in a plagiarism case; lessons of the ‘replication crisis’; special issues redux

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 265. There are more than 36,000 retractions in our database — which powers retraction alerts in EndNoteLibKeyPapers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

One thought on “Weekend reads: A bizarre turn in a plagiarism case; lessons of the ‘replication crisis’; special issues redux”

  1. Apparently, neither the peer reviewers nor the editors of this journal noticed that “there is no cell line named IM-9I.”
    The authors of three other papers were also convinced that “IM-9I” is a cell-line of human lymphocytes. The third one is definitely a product of a papermill. I haven’t checked the first two.
    Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305849/).
    MicroRNA-383-5p predicts favorable prognosis and inhibits the progression of diffuse large B-cell lymphoma
    The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.